Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.

The Trump administration is working to arrange private sector financing for Argentina that would double the total U.S.

The Trump administration has provided a $300 million infusion to a food aid program for low-income mothers and children, ...

The US Food and Drug Administration (FDA) has granted approval for Roche's Gazyva/ Gazyvaro (obinutuzumab) to treat adult ...

Critics have warned that lowered hiring standards and slashed training times will lead to an explosion of abuses by immigration officers ...

The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Some officials in President Donald Trump's administration are now starting to admit that the longer the federal government ...

NYU Abu Dhabi researchers have developed SPIRAL, a breakthrough brain implant that delivers drugs to multiple regions with ...

At a September Senate hearing, Health and Human Services Secretary Robert F. Kennedy Jr. boasted about a rural health ...

The Trump administration's mass deportation crackdown has sent waves through sanctuary cities Chicago and Portland in recent weeks.